Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs

10.9K views
•
November 10, 2025
by
CNBC Television
YouTube video player
Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs

Transcript

Fiser's up to10 billion dollar deal to buy MSA ended a fierce bidding war with Nova Nordisk. It's a move aimed at establishing Fizer in the very fast growing market for obesity drugs. Joining us now any first on CNBC interview to discuss the deal and who knows what else of course is company's chairman and CEO Albert Borla. Nice to have you here. Th... Read More

Explore YouTube Video Summarizer or Get YouTube Transcript Extractor

Read in Other Languages (beta)

English

Share This Summary 📚

Explore More Summaries from CNBC Television 📚

I wouldn't stick your neck out on Six Flags, says Jim Cramer thumbnail
I wouldn't stick your neck out on Six Flags, says Jim Cramer
CNBC Television
Citi CEO Jane Fraser: Some of the hype of in AI is earned, some of it is 'exuberant' thumbnail
Citi CEO Jane Fraser: Some of the hype of in AI is earned, some of it is 'exuberant'
CNBC Television
Private payrolls rose 42,000 in October, more than expected and countering labor market fears: ADP thumbnail
Private payrolls rose 42,000 in October, more than expected and countering labor market fears: ADP
CNBC Television
Mad Money 8/15/25 | Audio Only thumbnail
Mad Money 8/15/25 | Audio Only
CNBC Television
The reopening rally: Here's what you need to know thumbnail
The reopening rally: Here's what you need to know
CNBC Television
J.P. Morgan's Gabriella Santos: Fed cuts this cycle won’t inject extraordinary liquidity thumbnail
J.P. Morgan's Gabriella Santos: Fed cuts this cycle won’t inject extraordinary liquidity
CNBC Television